Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
10 2023
Historique:
received: 30 12 2022
revised: 19 04 2023
accepted: 18 06 2023
medline: 18 9 2023
pubmed: 15 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

Practice variation exists in venous resection during pancreatoduodenectomy, but little is known about the potential causes and consequences as large studies are lacking. This study explores the potential causes and consequences of practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer in the Netherlands. This nationwide retrospective cohort study included patients undergoing pancreatoduodenectomy for pancreatic cancer in 18 centers from 2013 through 2017. Among 1,311 patients undergoing pancreatoduodenectomy, 351 (27%) had a venous resection, and the overall median annual center volume of venous resection was 4. No association was found between the center volume of pancreatoduodenectomy and the rate of venous resections, nor between patient and tumor characteristics and the rate of venous resections per center. Female sex, lower body mass index, neoadjuvant therapy, venous involvement, and stenosis on imaging were predictive for venous resection. Adjusted for these factors, 3 centers performed significantly more, and 3 centers performed significantly fewer venous resections than expected. In patients with venous resection, significantly less major morbidity (22% vs 38%) and longer overall survival (median 16 vs 12 months) were observed in centers with an above-median annual volume of venous resections (>4). Patient and tumor characteristics did not explain significant practice variation between centers in the Netherlands in venous resection during pancreatoduodenectomy for pancreatic cancer. The clinical outcomes of venous resection might be related to the volume of the procedure.

Sections du résumé

BACKGROUND
Practice variation exists in venous resection during pancreatoduodenectomy, but little is known about the potential causes and consequences as large studies are lacking. This study explores the potential causes and consequences of practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer in the Netherlands.
METHODS
This nationwide retrospective cohort study included patients undergoing pancreatoduodenectomy for pancreatic cancer in 18 centers from 2013 through 2017.
RESULTS
Among 1,311 patients undergoing pancreatoduodenectomy, 351 (27%) had a venous resection, and the overall median annual center volume of venous resection was 4. No association was found between the center volume of pancreatoduodenectomy and the rate of venous resections, nor between patient and tumor characteristics and the rate of venous resections per center. Female sex, lower body mass index, neoadjuvant therapy, venous involvement, and stenosis on imaging were predictive for venous resection. Adjusted for these factors, 3 centers performed significantly more, and 3 centers performed significantly fewer venous resections than expected. In patients with venous resection, significantly less major morbidity (22% vs 38%) and longer overall survival (median 16 vs 12 months) were observed in centers with an above-median annual volume of venous resections (>4).
CONCLUSION
Patient and tumor characteristics did not explain significant practice variation between centers in the Netherlands in venous resection during pancreatoduodenectomy for pancreatic cancer. The clinical outcomes of venous resection might be related to the volume of the procedure.

Identifiants

pubmed: 37451894
pii: S0039-6060(23)00395-1
doi: 10.1016/j.surg.2023.06.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

924-933

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Jesse V Groen (JV)

Department of Surgery, Leiden University Medical Center, The Netherlands. Electronic address: j.v.groen@lumc.nl.

Nynke Michiels (N)

Department of Surgery, Leiden University Medical Center, The Netherlands.

Marc G Besselink (MG)

Department of Surgery, Amsterdam UMC, location University of Amsterdam, The Netherlands; Cancer Center Amsterdam, The Netherlands.

Koop Bosscha (K)

Department of Surgery, Jeroen Bosch Hospital, Den Bosch, The Netherlands.

Olivier R Busch (OR)

Department of Surgery, Amsterdam UMC, location University of Amsterdam, The Netherlands; Cancer Center Amsterdam, The Netherlands.

Ronald van Dam (R)

Department of Surgery, Maastricht University Medical Center, The Netherlands.

Casper H J van Eijck (CHJ)

Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

Bas Groot Koerkamp (BG)

Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

Erwin van der Harst (E)

Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.

Ignace H de Hingh (IH)

Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Epidemiology, Maastricht UMC+, The Netherlands.

Tom M Karsten (TM)

Department of Surgery, Onze Lieve Vrouwe Gasthuis (loc. Oost), Amsterdam, The Netherlands.

Daan J Lips (DJ)

Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.

Vincent E de Meijer (VE)

Department of Surgery, University of Groningen and University Medical Center Groningen, The Netherlands.

Isaac Q Molenaar (IQ)

Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein; Regional Academic Cancer Center Utrecht, The Netherlands.

Vincent B Nieuwenhuijs (VB)

Department of Surgery, Isala, Zwolle, The Netherlands.

Daphne Roos (D)

Department of Surgery, Reinier de Graaf Gasthuis, Delft, The Netherlands.

Hjalmar C van Santvoort (HC)

Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein; Regional Academic Cancer Center Utrecht, The Netherlands.

Jan H Wijsman (JH)

Department of Surgery, Amphia Hospital, Breda, The Netherlands.

Fennie Wit (F)

Department of Surgery, Tjongerschans Hospital, Heerenveen, The Netherlands.

Babs M Zonderhuis (BM)

Cancer Center Amsterdam, The Netherlands; Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.

Judith de Vos-Geelen (J)

Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, The Netherlands.

Martin N Wasser (MN)

Department of Radiology, Leiden University Medical Center, The Netherlands.

Bert A Bonsing (BA)

Department of Surgery, Leiden University Medical Center, The Netherlands.

Martijn W J Stommel (MWJ)

Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.

J Sven D Mieog (JSD)

Department of Surgery, Leiden University Medical Center, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH